Merrimack Pharmaceuticals (MACK) Earnings

Nov 3Confirmed
Mar 2022
May 2022
Aug 2022
Nov 2022
-0.67
-0.46
-0.25
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.033
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Merrimack Pharmaceuticals⁩ (⁦MACK⁩) has reported earnings of ⁦-0.033⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts